Carboplatin

卡铂

Report date: 2023/03/03 15:31:57
NME

Base Information

Drug NameCarboplatin
Drug Alias Name碳铂carboplatine铂帝carboplatinumcarboplatino +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlkylating agentsDNA synthesis inhibitors
TargetsNot applicable
Therapy Area/IndicationsCNS Embryonal TumorHormone-Resistant Prostate NeoplasmsSolid tumours +[24] 
Global Approved IndicationsSolid tumoursUrinary Bladder NeoplasmsUterine Cervical Neoplasms +[11] 
Approved Indications in ChinaUrinary Bladder NeoplasmsUterine Cervical NeoplasmsSmall Cell Lung Carcinoma +[8] 
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[16] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesCorden Pharma
China Registration ClassN/A

Develop Information

Active CompaniesHospiraIRCCS Azienda Ospedaliero-Universitaria di BolognaWake Forest University Health Sciences +[13] 
Inactive CompaniesUniversity of California IrvineCorden Pharma Latina SpaNational Institutes Of Health +[11] 
Active IndicationsHormone-Resistant Prostate NeoplasmsSolid tumoursFallopian Tube Diseases +[19] 
Inactive IndicationsCNS Embryonal TumorCarcinoma, Intraductal, NoninfiltratingEpendymoma +[5] 

Other Information

ATC CodeL01XA02
Related LinksWikipediaDrugBankKEGG